Artamonova, E.A.; Abdullatypov, A.V. Ellagic Acid Derivatives: Possible Drugs Against Metapneumovirus?. Preprints2022, 2022100055. https://doi.org/10.20944/preprints202210.0055.v1
APA Style
Artamonova, E.A., & Abdullatypov, A.V. (2022). Ellagic Acid Derivatives: Possible Drugs Against Metapneumovirus?. Preprints. https://doi.org/10.20944/preprints202210.0055.v1
Chicago/Turabian Style
Artamonova, E.A. and Azat Vadimovich Abdullatypov. 2022 "Ellagic Acid Derivatives: Possible Drugs Against Metapneumovirus?" Preprints. https://doi.org/10.20944/preprints202210.0055.v1
Abstract
Human metapneumovirus is one of major causes of common cold among children, especially infants. Its key enzyme is RNA-dependent RNA-polymerase, which performs both replication and transcription, including capping and cap methylation. The goal of the work is to find possible inhibitors of RNA-dependent RNA-polymerase across the active compounds of Rosaceae plants. The candidates were selected by molecular docking to cap-transferring domain of RNA-polymerase (PDB ID: 4UCZ) in Autodock VINA. Among all the substances tested by docking, ellagic acid derivatives showed the most promising results (affinity values below -10 kcal/mol). Hence, they could be treated as possible candidate drugs against metapneumoviral infection after experimental examination. The main advantage of using these substances should be their low toxicity, which is quite uncommon for selective RNA polymerase inhibitors used in clinical practice. Occurrence of ellagic acid derivatives among the plants from Rosaceae family like raspberry could explain their effect during common cold.
Biology and Life Sciences, Biochemistry and Molecular Biology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
